Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-22

Clinical Trial Update: Vinorelbine Plus Capecitabine Versus Docetaxel Plus Capecitabine in Anthracycline-pretreated Women With Metastatic Breast Cancer

View source ↗

Summary

This clinical trial compares vinorelbine plus capecitabine to docetaxel plus capecitabine in women with metastatic breast cancer who have previously received an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • DOCETAXEL (DOCETAXEL)
  • Vinorelbine (Vinorelbine)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Anthracycline-pretreated Metastatic Breast Cancer | Status: UNKNOWN